Clinical Bioanalysis

CANTEST Life Sciences provides high-volume GLP bioanalytical support throughout the clinical drug development process, from Phase I to Phase IV.  The laboratory conducts clinical bioanalyses using LC-MS-MS for the following types of clinical trials:

• “First-in-Man” Trials
• Dose-finding/Dose-escalation Studies
• Pharmacokinetic (PK) Studies
• Pharmacokinetic/Pharmacodynamic (PK/PD) Studies
• Bioavailability (BA) Studies
• Bioequivalence (BE) Studies
• Drug-Drug Interaction (DDI) Studies
• Food Effect Studies
• Therapeutic Drug Monitoring Studies
• Phase II or Phase III Clinical Trials with a PK Component
• Fetal and Maternal Drug and/ or Drug Metabolite Disposition Studies

Please click here for a list of validated, non-exclusive LC-MS-MS and LC-MS assays. These assays involve bioanalysis of drugs and/ or metabolites in plasma or urine in support of clinical trials.

If you require an assay that is not on this list, please inquire.